Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elara MD vs Medi-Weightloss

Elara MD
Graded #467

Lower grade

vs+16.099999999999994
Medi-Weightloss
Graded #126

Higher grade

The verdict

Medi-Weightloss takes it — 69.6/100 to 53.5/100.

Medi-Weightloss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medi-Weightloss is an established physician-supervised weight-loss brand with 130-plus locations nationwide plus telehealth.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedi-Weightloss +14
40
54
Dose & formulationMedi-Weightloss +11
54
65
Clinical oversightMedi-Weightloss +24
63
87
Labs & monitoringMedi-Weightloss +38
52
90
FulfillmentElara MD +1
66
65
Contract termsEven
55
55
Elara MD · left barMedi-Weightloss · right bar

The numbers

MetricElara MDMedi-Weightloss
WeighScore53.5/10069.6/100
GradeCC
Scorecard rank#467#126
Semaglutide$249/mo (0.2 mg dose, compounded)$199/mo (promotional rate, brand-name)
Tirzepatide$349/mo (2.0 mg dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Elara MD

Graded #467 · C

Strengths

  • Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
  • Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
  • Medication included in the monthly price with free fast shipping when prescribed
  • Broad reach claimed (over 40 states)

Where it loses points

  • Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
  • No FDA compounded-medication disclaimer published
  • No named compounding pharmacy partner — prescriptions are patient-directed
  • LegitScript certification, medical director, and full state list not disclosed
  • Pricier than several compounded competitors
Medi-Weightloss

Graded #126 · C

Strengths

  • Both branded (Wegovy, Zepbound) and compounded semaglutide/tirzepatide
  • Established brand with 130+ physician-supervised locations nationwide
  • Telehealth plus in-person clinic options
  • Accepts insurance at many locations; HSA/FSA welcome
  • Includes body-composition analysis and personalized plans

Where it loses points

  • Ongoing medication pricing not transparently posted; varies by plan
  • $199 new-patient visit fee before medication costs
  • Frequent (often weekly) visits expected for some patients
  • Compounded products are not FDA-approved or evaluated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard